Search
for
Sort by
Research 841–870 of 1000+
- Comparative efficacy and safety of systemic steroids, oral JAK inhibitors and Contact Immunotherapy in the Treatment of severe alopecia areata: a systematic review and network meta-analysis
- Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis
- Alopecia areata: What’s new in the epidemiology, comorbidities, and pathogenesis?
- CO149 Does the EQ-5D Measure the Full Impact of Alopecia Areata on Patients' Health Related Quality of Life?
- 52874 Timing of eyebrow and eyelash regrowth among subgroups of scalp responders during treatment of severe alopecia areata with baricitinib
- EE325 Budget Impact of Baricitinib for Patients with Severe Alopecia Areata
- Benefit of different concentrations of intralesional triamcinolone acetonide in alopecia areata: An intrasubject pilot study
- Current and future treatments of alopecia areata and trichotillomania in children
- 51721 Analysis for recurrence of alopecia areata after immunotherapy with diphenylcyclopropenone in 113 patients: A single-institution retrospective analysis
- A Case of Unexpected Successful Treatment of Alopecia Areata With Tralokinumab in a Patient With Atopic Dermatitis
- Janus kinase inhibitors for alopecia areata: A narrative review
- Autoimmune associations of alopecia areata in pediatric population - A study in tertiary care centre
- Trichohyalin is a Potential Major Autoantigen in Human Alopecia Areata
- An investigation of vitamin D status in alopecia areata
- Cardiovascular risk in patients with alopecia areata (AA): A propensity-matched retrospective analysis
- Best dilution of the best corticosteroid for intralesional injection in the treatment of localized alopecia areata in adults
- The Alopecia Areata Severity and Morbidity Index (ASAMI) Study
- A Study to Evaluate the Efficacy of Various Topical Treatment Modalities for Alopecia Areata
- Association of Sensorineural Hearing Loss in Patients With Alopecia Areata
- Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
- Patient-reported outcome improvements following scalp hair regrowth among patients with Alopecia Areata: analysis of the ALLEGRO-2b/3 trial
- A prospective study on the efficacy of platelet rich plasma in alopecia areata
- Evaluation of platelet-rich plasma in treatment of alopecia areata
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
- Prognostic Factors in Mexican Patients with Patchy and Other Types of Alopecia Areata
- Comparative efficacy of topical calcipotriol and tacrolimus in alopecia areata: A prospective trial
- 44313 Self-Stigmatization and Alopecia Areata; Exploring the Role of Social Support, Helplessness, and Illness Acceptance
- 42004 Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study
- LB1053 Dysregulation of antioxidant enzyme PRDX5 in alopecia areata
- Parenting styles and psychological effects on children with alopecia areata: exploring family dynamics, anxiety, and depression